Medistik Dual Hot and Cold

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary soothing relief of sore muscles associated with strains and sprains, backaches, lumbago, pain of tendons and/or ligaments, as well as arthritic or rheumatic pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This medication is indicated for use in adults and children over 12 years of age. For children aged 12 years, application should be supervised by an adult to ensure proper use.

The recommended dosage involves applying a thin and even layer of the solution to the affected area. This application may be performed up to 3 to 4 times per day. It is essential to rub and/or massage the solution into the skin until it is completely absorbed and no longer visible.

In cases of arthritis or muscle pain specifically affecting the hands, it is advised to allow the solution to remain on the skin for a minimum of 10 minutes before washing the hands.

Healthcare practitioners should be consulted if the treatment is required for more than 7 consecutive days to ensure safety and efficacy.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only, this product should be applied with caution to prevent adverse effects. It is imperative to avoid contact with the eyes and mucous membranes, as such contact may lead to irritation. The product must not be applied to wounds or damaged skin, and it should not be tightly bandaged to ensure proper skin ventilation.

Inhalation of the product is contraindicated, and it should not be used in conjunction with external heat sources, such as electric heating pads, as this may lead to excessive skin irritation or burns. To ensure safety, the product must be kept out of the reach of children. In the event of an overdose or accidental ingestion, immediate contact with a Poison Control Center is essential.

Healthcare practitioners should be consulted prior to use in specific populations, including pregnant or breastfeeding individuals, as well as those taking anticoagulant medications or other medications and natural health products that may cause vasodilation.

Users should be aware that rashes, burning discomfort, and hypersensitivity reactions, including allergies, have been reported. In such cases, discontinuation of use is advised. Regular monitoring for any adverse reactions is recommended to ensure patient safety.

Side Effects

Adverse reactions associated with the use of this medication include rashes, burning discomfort, and hypersensitivity reactions, such as allergy. In cases where these reactions occur, it is advised to discontinue use of the medication.

Patients should be monitored for these adverse reactions, and appropriate measures should be taken if they arise. The occurrence of these reactions underscores the importance of careful patient assessment and management during treatment.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Medistik Dual Hot and Cold (methyl salicylate, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use this medication, with application supervised by an adult. The recommended dosage involves applying a thin, even layer to the affected area up to 3 to 4 times daily. The solution should be rubbed and/or massaged into the skin until it is fully absorbed.

It is important to note that a stinging or burning sensation may occur during the initial minutes of application as the formula begins to take effect. Healthcare practitioners should be consulted if treatment is required for more than 7 days.

Geriatric Use

Elderly patients should consult their healthcare practitioner prior to use, particularly if they are pregnant, breastfeeding, or taking anticoagulant medications. Additionally, caution is advised for those using medications or natural health products that may cause dilation of blood vessels. It is essential for healthcare providers to monitor geriatric patients closely under these circumstances to ensure safety and efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult their healthcare practitioner prior to using this medication. It is essential to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. Healthcare professionals should consider the available data and individual patient circumstances when advising women of childbearing potential regarding the use of this medication.

Lactation

Lactating mothers are advised to consult their healthcare practitioner prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when recommending this medication to lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose or accidental ingestion, it is imperative to contact a Poison Control Center without delay. Prompt action is essential to ensure the safety and well-being of the patient.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is necessary to determine the appropriate course of action.

Management of an overdose may include supportive care and symptomatic treatment as required. Continuous monitoring of the patient's vital signs and clinical status is recommended to address any complications that may arise.

In all cases of suspected overdose, the guidance of a Poison Control Center should be sought to facilitate effective management and intervention strategies.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified reports of rashes, burning discomfort, and hypersensitivity reactions, including allergic responses. In instances of such events, it is advised to discontinue use of the product.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with improper access to the medication, ensuring that patients understand the necessity of safeguarding it in their home environment.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the product from light exposure to maintain its integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the affected area up to three to four times daily. Patients are advised to consult their healthcare practitioner prior to use if they are pregnant, breastfeeding, or taking anticoagulant medications, as well as if they are using any medications or natural health products that may cause dilation of blood vessels. Additionally, consultation is recommended for use beyond a duration of seven days.

No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Medistik Dual Hot and Cold, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)